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Pcptidc:N-glycanascs (PNGascs) removes N-linked glycans from glycoprotcins. Three 
distinct families of PNGascs have been characterised, although all of them not completely. 
Some of these PNGascs arc cytosolic, others arc secreted. Cytoplasmic PNGascs (Png Ip) 
arc imp licatcd in the protcasomal degradation o f newly synthesized mis fo ldcd or unfo ldcd 
glycoprotcins that arc exported from the endoplasmic reticulum (ER). Cytoplasmic 
PNGascs arc encoded by the PNC I gene and ha ve been classified as members of 
transglutaminasc-likc supcrfamily based on the sequence analyses. There has, however, 
been no report of transglutaminasc activity in any PNGasc. The three-dimensional 
structures of recombinant PNGascs from yeast (S. cerevisiae) and mouse have been 
determined in complex with the XPCB domain of Rad23 and mHR238 respectively. 
These PNGascs were both produced as insoluble proteins, and could only be refolded and 
crysta llised in the presence of their phys iological bind ing partners. 
In this study, the gene encoding for S. pombe P Gase has been cloned and hctcrologously 
expressed as a soluble thiorcdoxin- fu scd protein . The proteolytic cleaved recombinant 
protein (rP Gase Sp) remained so luble as a monomer and reta ined its dcglycosylating 
act ivity. It did not have, however any transglutaminasc activity despite its homology to the 
transglutaminase fami ly o f proteins. The activity o f rPNGase Sp in vitro is both reductant 
and Zn2- dependent. rP Gase Sp showed apparent heterogeneity on SDS-PAG E, which 
was characterised by the appearance o f two bands differing in their molecular weights by 
an - 2.3 kDa. This heterogeneity was eventua lly shown to be the resu lt o f two different 
local conformations that were dependent on disulfide bond and/o r Zn2+. The enzyme was 
shown to only deglycosylatc the denatured glycoprotcins, not their native counterparts. 
Moreover, it preferred to dcglycosylatc glycoprotcins with high mannosc- typc glycan 
chains, both of which arc consistent with the biological function of cytoplasmic PNGascs. 
Compared to bacterial PNGasc F, rPNGasc Sp is not very active, at least on the substrate 
used in this study. A higher Km ( 186 µM ) determined for rPNGasc Sp using a FITC-
labcllcd glycopcptidc which carries a complex-type glycan as the substrate also suggests 
that complex glycans arc not favoured substrates for these PNGascs. rPNGascSp has 
similar characteristics to the yeast (S. cerevisiae) and mouse PNGascs; it has a neutral pH 
optimum and is strongly inhibited by Cu2+, Cd2+ and N j2+_ EDT A treatment deactivates it, 
and the addition of Zn2+ could not restore its activity. Interestingly, addition of exogenous 
Zn2+ was found to strongly inh ibit rPNGasc Sp. 
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